Noninvasive assessment of characteristics of novel anti-HER2

HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death

Full article: Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER2 Positive Breast Cancer Cells

Frontiers Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications

Cancers, Free Full-Text

HER2 targeted noninvasive immunosensor based on pencil graphite electrode for detection of breast cancer - ScienceDirect

124I-labeled anti-CD147 antibody for noninvasive detection of CD147-positive pan-cancers: construction and preclinical studies

New Approach May Help Predict HER2+ Tumor Response to Treatment – Consult QD

Cancers, Free Full-Text

Biomedicines, Free Full-Text

IJMS, Free Full-Text

Cancers, Free Full-Text

Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence - ScienceDirect

The landscape of d16HER2 splice variant expression across HER2-positive cancers